Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,793 public trials 5,051 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

NCT04910685

Conditions
Immune System Diseases, Indolent Systemic Mastocytosis, Mast Cell Activation Disorders, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus Aurora, Colorado, United States
View all 75 locations
View Trial Details
Recruiting

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

NCT06441331

Conditions
CNS Tumors, Central Nervous System Neoplasms, GIST, +29 more
Locations
  • The Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
  • Gustave Roussy Cancer Campus Villejuif, France
  • Hospital Universitario Vall d'Hebron - Oncología Médica Barcelona, Spain
View Trial Details
Recruiting

This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.

NCT07115017

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Washington University in St. Louis St Louis, Missouri, United States
View Trial Details
Recruiting

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

NCT06177067

Conditions
Acute Leukemia of Ambiguous Lineage, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Children's Mercy Hospital of Kansas City Kansas City, Missouri, United States
View Trial Details

Related conditions